Pancreatic RAS

Advances in Experimental Medicine and Biology

Volumn 690, Issue , 2010, Pages 89-105

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMYLASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSIN[1-7]; ANGIOTENSINOGEN; CAPTOPRIL; CHOLECYSTOKININ; CHOLESTEROL ESTERASE; CHYMOTRYPSIN; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KALLIKREIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PRORENIN; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; TRYPSIN; UNINDEXED DRUG; VASCULOTROPIN;

ACINAR CELL; APOPTOSIS; ARTICLE; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; DRUG EFFECT; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREAS DUCT; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET DELTA CELL; PANCREATIC STELLATE CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CYTOLOGY; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; ISLETS OF LANGERHANS; PANCREAS; PANCREAS, EXOCRINE; PANCREATIC DUCTS; PANCREATIC STELLATE CELLS; RENIN-ANGIOTENSIN SYSTEM;

EID: 79956218834     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-90-481-9060-7_6     Document Type: Article

References (78)

1. Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: A meta-analysis of randomized clinical trials. J Am Coll Cardiol 46:821-826, 2005. (Pubitemid 41224805)
2. Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ and Arafat HA. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg 12:57-66, 2008.
3. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC and Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43:128-133, 1998. (Pubitemid 28335501)
4. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC and Wilson JS. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 44:534-541, 1999. (Pubitemid 29169954)
5. Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT and Yeo CJ. Antihypertensives as novel antineoplastics: Angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. J Am Coll Surg 204:996-1005, 2007. (Pubitemid 46661215)
6. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V and Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118:1149-1156, 2000. (Pubitemid 30346992)
7. Bateman A, Turner S, Thomas K, McCrudden P, Fine D, Johnson P, Johnson C and Iredale J. apoptosis and proliferation of acinar and islet cells in chronic pancreatitis: evidence for differential cell loss mediating preservation of islet function. Gut 50:542-548, 2002. (Pubitemid 34638876)
8. Campbell D and Habener J. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 78:31-39, 1986. (Pubitemid 16068178)
9. Carlsson PO, Berne C and Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127-133, 1998. (Pubitemid 28088387)
10. Chan H, Law S, Leung P, Fu L andWong P. Angiotensin II receptor type I-regulated anion secretion in cystic fibrosis pancreatic duct cells. J Membr Biol 156:241-249, 1997. (Pubitemid 27208426)
11. Chappell M, Diz D and Gallagher P. The renin-angiotensin system and the exocrine pancreas. JOP 2:33-39, 2001. (Pubitemid 38963882)
12. Chappell M, Jacobsen D and Tallant E. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides 16:741-747, 1995.
13. Chappell M, Millsted A, Diz D, Brosnihan K and Ferrario C. Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens 9:751-759, 1991.
14. Chappell MC, Diz DI and Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides 13:313-318, 1992.
15. Chehl N, Gong Q, Chipitsyna G, Aziz T, Yeo CJ and Arafat HA. Angiotensin II Regulates the Expression of Monocyte Chemoattractant Protein-1 in Pancreatic Cancer Cells. J Gastrointest Surg 13:2189-2200, 2009.
16. Cheng H, So S, Law S and Chan H. Angiotensin II-mediated signal transduction events in cystic fibrosis pancreatic duct cells. Biochim Biophys Acta 1449:254-260, 1999. (Pubitemid 29164382)
17. Cheng Q, Law PK, de Gasparo M and Leung PS. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2- cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)- [1,1′-biphenyl]-4-yl] methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. J Pharmacol Exp Ther 327:683-691, 2008.
18. Cheung WT, Yeung SY, Yiu AK, Ip TM, Wan DC, Luk SK and Ho WK. Characterization of a functional AT1A angiotensin receptor in pancreatoma AR4-2 J cells. Peptides 20:829-836, 1999. (Pubitemid 29378284)
19. Chipitsyna G, Gong Q, Gray CF, Haroon Y, Kamer E, Arafat HA (2007) Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells. Endocrinology 148:2198-2208, 2007. (Pubitemid 46997051)
20. Christophe J. Pancreatic tumoral cell line AR42J: An amphicrine model. Am J Physiol 266: G963-G971, 1994.
21. Chu KY, Lau T, Carlsson PO and Leung PS. Angiotensin II type 1 receptor blockade improves betacell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55:367-374, 2006. (Pubitemid 43343265)
22. Chu KY and Leung PS. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Redox Signal 9:869-878, 2007. (Pubitemid 46919590)
23. Chu KY and Leung PS. Angiotensin II in type 2 diabetes mellitus. Curr Protein Pept Sci 10:75-84, 2009.
24. Chu KY, Cheng Q, Chen C, Au LS, Seto SW, Tuo Y, Motin L, Kwan YW and Leung PS. Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic beta-cells via angiotensin II type 2 receptors. Am J Physiol Cell Physiol 298:C313-323, 2010.
25. Cox HM, Cuthbert AW and Munday KA. The effect of angiotensin II upon electrogenic ion transport in rat intestinal epithelia. Br J Pharmacol 90:393-401, 1987. (Pubitemid 17232870)
26. Fink AS,Wang Y, Mendez T,Worrell RT, Eaton D, Nguyen TD and Lee SP. Angiotensin II evokes calcium-mediated signaling events in isolated dog pancreatic epithelial cells. Pancreas 25: 290-295, 2002.
27. Fujita M, Hayashi I, Yamashina S, Itoman M and Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294:441-447, 2002. (Pubitemid 34694114)
28. Garber AJ. Perspectives in type 2 diabetes: incorporating the latest insulin analogue strategies to achieve treatment success. Diabetes Obes Metab 11(Suppl 5):III-IV, 2009.
29. Githens S. The pancreatic duct cell: proliferative capabilities, specific characteristics, metaplasia, isolation, and culture. J Pediatr Gastroenterol Nutr 7:486-506, 1988.
30. Hama K, Ohnishi H, Aoki H, Kita H, Yamamoto H, Osawa H, Sato K, Tamada K, Mashima H, Yasuda H and Sugano K. Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway. Biochem Biophys Res Commun 340:742-750, 2006. (Pubitemid 43053893)
31. Hama K, Ohnishi H, Yasuda H, Ueda N, Mashima H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K and Sugano K. Angiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation. Biochem Biophys Res Commun 315:905-911, 2004. (Pubitemid 38249389)
32. Hashimoto T, Yamada T, Yokoi T, Sano H, Ando H, Nakazawa T, Ohara H, Nomura T, Joh T and Itoh M. Apoptosis of acinar cells is involved in chronic pancreatitis in Wbn/Kob rats: role of glucocorticoids. Pancreas 21:296-304, 2000.
33. Hirata AE, Morgan D, Oliveira-Emilio HR, Rocha MS, Carvalho CR, Curi R and Carpinelli AR. Angiotensin II induces superoxide generation via NAD(P)H oxidase activation in isolated rat pancreatic islets. Regul Pept 153:1-6, 2009.
34. Howard-McNattMand Fink AS. Captopril inhibits secretin-induced pancreatic bicarbonate output. J Surg Res 103:96-99, 2002.
35. Huang Z, Jansson L and Sjoholm A. Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats. Clin Sci (Lond) 112: 69-76, 2007. (Pubitemid 46120087)
36. Ishidoya S, Morrissey J, McCracken R, Reyes A and Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995.
37. Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM and Powell EE. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 121:148-155, 2001. (Pubitemid 32591525)
38. Kida Y, Asahina K, Inoue K, Kawada N, Yoshizato K, Wake K and Sato T. Characterization of vitamin A-storing cells in mouse fibrous kidneys using Cygb/STAP as a marker of activated stellate cells. Arch Histol Cytol 70:95-106, 2007. (Pubitemid 47395205)
39. Ko S, Kwon H, Kim S, Moon S, Ahn Y, Song K, Son H, Cha B, Lee K, Son H, Kang S, Park C, Lee I and Yoon K. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun 316:114-122, 2004. (Pubitemid 38299135)
40. Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, Son HY, KimMJ, Jeong IK and Yoon KH. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 98:343-355, 2006.
41. Korc M. Pathways for aberrant angiogenesis in pancreatic cancer. Mol Cancer 2:1-8, 2003.
42. Kordes C, Sawitza I and Haussinger D. Hepatic and pancreatic stellate cells in focus. Biol Chem 390:1003-1012, 2009.
43. Kuno A, Yamada T, Masuda K, Ogawa K, SogawaM, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T and Itoh M. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 124:1010-1019, 2003. (Pubitemid 36389804)
44. Lam KY and Leung PS. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur J Endocrinol 146:567-572, 2002. (Pubitemid 34436471)
45. Lau T, Carlsson P and Leung P. Evidence for a local angiotensin- generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47:240-248, 2004. (Pubitemid 38315360)
46. Leung PS and De Gasparo M. Novel peptides and proteins in diabetes mellitus. Curr Protein Pept Sci 10:1, 2009.
47. Leung KK and Leung PS. Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line. JOP 9:290-299, 2008. (Pubitemid 351864889)
48. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol 580: 31-37, 2007. (Pubitemid 46470642)
49. Leung PS and Carlsson PO. Pancreatic islet renin-angiotensin system: its novel roles in islet function and in diabetes. Pancreas 30:293-298, 2005. (Pubitemid 40586804)
50. Leung PS and Chappell MC. A local pancreatic renin-angiotensin system: endocrine and endocrine roles. Int J Biochem Cell Biol 35:838-846, 2003. (Pubitemid 36379325)
51. Leung PS, Chan WP, Wong TP and Sernia C. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 160:13-19, 1999. (Pubitemid 29044563)
52. Leung PS, Chan HC and Wong PY. Immunohistochemical localization of angiotensin II in the mouse pancreas. Histochem J 30:21-25, 1998. (Pubitemid 28154710)
53. Leung PS, Chan HC, Fu LX and Wong PY. Localization of angiotensin II receptor subtypes AT1and AT1 in the pancreas of rodents. J Endocrinol 153:269-274, 1997a. (Pubitemid 27219459)
54. Leung PS, Chan HC, Fu LX, Zhou WL and Wong PY. Angiotensin II receptors, AT1and AT1 in the rat epididymis: immunocytochemical and electrophysiological studies. Biochim Biophys Acta 1357:65-72, 1997b. (Pubitemid 27239333)
55. Liu WB, Wang XP, Wu K and Zhang RL. Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. World J Gastroenterol 11:6489-6494, 2005. (Pubitemid 43136886)
56. Masamune A, Watanabe T, Kikuta K and Shimosegawa T. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol 7:S48-S54, 2009.
57. Musch MW, Li YC and Chang EB. Angiotensin II directly regulates intestinal epithelial NHE3 in Caco2BBE cells. BMC Physiology 9:1-8, 2009.
58. Nagashio Y, Asaumi H, Watanabe S, Nomiyama Y, Taguchi M, Tashiro M, Sugaya T and Otsuki M. Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice. Am J Physiol 287:G170-G177, 2004. (Pubitemid 38802131)
59. Norris B, Gonzalez C, Concha J, Palacios S and Contreras G. Stimulatory effect of angiotensin II on electrolyte transport in canine tracheal epithelium. Gen Pharmacol 22:527-531, 1991.
60. Omary MB, Lugea A, Lowe AW and Pandol SJ. The pancreatic stellate cell: A star on the rise in pancreatic diseases. J Clin Invest 117:50-59, 2007. (Pubitemid 46048449)
61. Paul M, Poyan Mehr A and Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86:747-803, 2006. (Pubitemid 44033382)
62. Pollare T, Lithell H and Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873, 1989. (Pubitemid 19238619)
63. Regoli M, Bendayan M, Fonzi L, Sernia C and Bertelli E. Angiotensinogen localization and secretion in the rat pancreas. J Endocrinol 179:81-89, 2003. (Pubitemid 37321570)
64. Reinehr R, Zoller S, Klonowski-Stumpe H, Kordes C and Haussinger D. Effects of angiotensin II on rat pancreatic stellate cells. Pancreas 28:129-137, 2004. (Pubitemid 38269772)
65. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN and Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89: 2273-2282, 1994. (Pubitemid 24142808)
66. Sealey JE, Catanzaro DF, Lavin TN, Gahnem F, Pitarresi T, Hu LF and Laragh JH. Specific prorenin/renin binding (ProBP). Identification and characterization of a novel membrane site. Am J Hypertens 9:491-502, 1996.
67. Sernia C. Location and secretion of brain angiotensinogen. Regul Pept 57:1-18, 1995.
68. Shimizu K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol 43:823-832, 2008.
69. TahmasebiM, Puddefoot J, Inwang E and Vinson G. The tissue renin-angiotensin system in human pancreas. J Endocrinol 161:317-322, 1999. (Pubitemid 29244259)
70. Tikellis C, Wookey P, Candido R, Andrikopoulos S, Thomas M and Cooper M. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 53: 989-997, 2004. (Pubitemid 38436611)
71. Tsang SW, Cheng HK, Leung PS. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 119:213-219, 2004. (Pubitemid 38553840)
72. Wang R, Ramos C, Joshi I, Zagariya A, Pardo A, Selman M and Uhal BD. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol 277:L1158-L1164, 1999. (Pubitemid 30046043)
73. Wong P, Lee S and Cheung W. Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas. Regul Pept 117:195-205, 2004. (Pubitemid 38121655)
74. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 214:199-210, 2008. (Pubitemid 351160157)
75. Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, Ando T, Sano H, Nakazawa T, Ohara H, Nomura T, Joh T and Itoh M. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 307:17-23, 2003. (Pubitemid 37151887)
76. Yin G, Yan C and Berk BC. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 35:780-783, 2003. (Pubitemid 36379319)
77. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H and Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34:745-750, 2001. (Pubitemid 32927999)
78. Yoshikawa H, Kihara Y, Taguchi M, Yamaguchi T, Nakamura H and Otsuki M. Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 282:G549-G558, 2002. (Pubitemid 34651670)